Drugs like Ozempic, Wegovy and Mounjaro are changing the game for weight loss. GLP-1 medications were originally intended to ...

I'm cautious about Novo Nordisk's short-term prospects due to the recent selloff, but see long-term potential with high ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

While weight loss is a common new year's resolution for workers in the U.S., 2025 may mark the year that building weight loss ...

Semaglutide (known by its brand name Ozempic) has gained widespread attention for its weight-loss benefits, but is officially ...

A new generation of weight loss drugs has helped some people lose significant amounts of weight and improve their health.

Diabetes and weight-loss medications, known as GLP-1 or incretin drugs, have taken the world by storm — especially the United ...

January is a big time for drugmakers to hike prices. This year saw higher prices for 575 medications so far, including ...

Drugs like Ozempic and Wegovy are now costing Connecticut taxpayers about $60 million this year and that figure could rise ...

Monday, Dec. 2, 2024. (AP Photo/Kathleen Batten ... Kennedy Jr., Trump's nominee for Health and Human Services Secretary, has ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

Interested in an oral alternative to Ozempic injections? You might be considering metformin, an FDA-approved type 2 diabetes ...